Teoría causal, síntomas motores, síntomas no motores, diagnóstico y tratamiento de la Enfermedad de Parkinson: una revisión bibliográfica
DOI:
https://doi.org/10.33448/rsd-v11i7.29762Palabras clave:
Enfermedad de Parkinson; Levodopa; Síntomas clínicos; Diagnóstico clínico; Enseñanza en Salud.Resumen
La Enfermedad de Parkinson (EP) se presenta en senescencia, limitando el movimiento y progresando a demencia, siendo así la segunda enfermedad neurodegenerativa relacionada con la edad en el mundo. Por lo tanto, esta revisión de la literatura tiene como objetivo recopilar información relevante sobre la EP para orientar nuevos enfoques científicos que favorecerán la aplicación clínica y, por lo tanto, la calidad de vida de los pacientes con EP. Se seleccionaron y analizaron 80 estudios publicados en los últimos 20 años en una base de datos con descriptores indexados. El resultado observado conduce a la comprensión de teorías causales, síntomas motores y no motores, diagnóstico y tratamiento. Se concluyó que el estudio orienta, a partir de la información recopilada, nuevos estudios experimentales para mejorar la calidad de vida de los pacientes con EP.
Citas
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Chaudhuri, K. R. & Weintraub, D. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7, 47. https://doi.org/10.1038/s41572-021-00280-3.
Abreu, G. M., Valença, D. C., Campos, M. Júnior, da Silva, C. P., Pereira, J. S., Araujo , Leite M. A., Rosso, A. L., Nicaretta, D. H., Vasconcellos, L.F., da Silva, D. J., Della Coletta, M. V., Dos Santos, J. M., Gonçalves, A. P., Santos-Rebouças, C. B. & Pimentel, M. M. (2016). Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Neurosci Lett. 635, 67-70. https://doi.org/10.1016/j.neulet.2016.10.040.
Albers, J. A., Chand, P. & Anch, A. M. (2017). Multifactorial sleep disturbance in Parkinson's disease. Sleep medicine. 35(41), 48. https://doi.org/10.1016/j.sleep.2017.03.026.
Alifirova, V. M., Zhukova, N. G., Zhukova, I. A., Latypova, A. V., Titova, M. A., Mironova, Y. S., Izhboldina, O. P., Nikitina, M. A. & Petrov, V. A. (2016). A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(11),174-179. https://doi.org/10.17116/jnevro2016116111174-179.
Amaro, E. JR. & Yamashita, H. (2001). Aspectos básicos de tomografia Aspectos básicos de tomografia computadorizada e ressonância computadorizada e ressonância, magnética. Rev Bras Psiquiatr. 23(1), 2-3. https://doi.org/10.1590/S1516-44462001000500002.
Barbosa, E. R. & Sallem, F. A. S. (2005). Parkinson´s Disease – Diagnosis. Rev Neurociencias, 13(3), 158-165. https://doi.org/10.34024/rnc.2005.v13.8827.
Beitz, J. M. (2014). Parkinson's disease: a review. Frontiers in bioscience. 6(1), 65-74. https://doi.org/10.2741/s415.
Benadiba, M., Luurtsema, G., Wichert-Ana, L., Buchpigel, C. A. & Filho, G. B. (2012). New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Revista Brasileira de Psiquiatria. 34(2), s125-s148. https://doi.org/10.1016/j.rbp.2012.08.002.
Berg, D., Postuma, R. B., Bloem, B., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Hardy, J., Lang, A. E., Litvan, I., Marek, K., Obeso, J., Oertel, W., Olanow, C. W., Poewe ,W., Stern, M. & Deuschl, G. (2014). Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society. 29(4), 454-62. https://doi.org/10.1002/mds.25844.
Berger, A. (2002). Magnetic resonance imaging. BMJ (Clinical research ed.), 324(7328), 35. https://doi.org/10.1136/bmj.324.7328.35.
Bose, A. & Beal, M. F. (2016). Mitochondria and Parkinson’s disease. J.Neurochem. 139 Suppl. 1, 216–231. https://doi.org/10.1111/jnc.13731.
Braak, H., Del Tredici, K., Rub, U., De Vos, R. A., Jansen Steur, E. N. & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging. 24(2), 197-211. https://doi.org/10.1016/s0197-4580(02)00065-9.
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H. & Del Tredici, K. (2004). Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318(1), 121-34. https://doi.org/10.1007/s00441-004-0956-9.
Burré, J., Sharma, M., & Südhof, T. C. (2018). Cell Biology and Pathophysiology of α-Synuclein. Cold Spring Harbor perspectives in medicine, 8(3), a024091. https://doi.org/10.1101/cshperspect.a024091.
Cedikova, M., Pitule, P., Kripnerova, M., Markova, M. & Kuncova, J. (2016). Multiple roles of mitochondria in aging processes. Physiological research. 65(Suppl 5), S519-S531. https://doi.org/10.33549/physiolres.933538.
Chung, S., Lee, E. J., Yun, S., Choe, H. K., Park, S. B., Son, H. J., Kim, K. S., Dluzen, D. E., Lee, I., Hwang, O., Son, G. H. & Kim, K. (2014). Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation. Cell. 157(4), 858-68. https://doi.org/10.1016/j.cell.2014.03.039.
Deitos, M. V. & Trippo, K. V. (2017). Evaluation of posture image in Parkinson´s disease: A developmental study. Revista Pesquisa Em Fisioterapia, 7(4), 462–469. https://doi.org/10.17267/2238-2704rpf.v7i4.1569.
Díaz-Santos, M., Cao B., Yazdanbakhsh, A., Norton, D. J., Neargarder, S. & Cronin-Golomb, A. (2015). Perceptual, cognitive, and personality rigidity in Parkinson's disease. Neuropsychologia. 69, 183-93. https://doi.org/10.1016/j.neuropsychologia.2015.01.044.
Dirkx, M. F., Zach H., Bloem, B. R., Hallett, M. & Helmich, R. C. (2018). The nature of postural tremor in Parkinson disease. Neurology. 90(13), e1095-e1103. https://doi.org/10.1212/WNL.0000000000005215.
Falup-Pecurariu & Diaconu, Ş. (2017). Sleep Dysfunction in Parkinson's Disease. Int Rev Neurobiol. 133, 719-742. https://doi.org/10.1016/bs.irn.2017.05.033.
Fields, J. A. (2017). Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias. Arch Clin Neuropsychol. 32(7), 786-801. https://doi.org/10.1093/arclin/acx085.
Fois, A. F., Briceño, H. M., Fung, V. S. C. (2017). Nonmotor Symptoms in Essential Tremor and Other Tremor Disorders. Int Rev Neurobiol. 134, 1373-1396. https://doi.org/10.1016/bs.irn.2017.05.010.
Foley, J. A., Foltynie, T., Zrinzo, L., Hyam, J. A., Limousin, P., & Cipolotti, L. (2017). Apathy and reduced speed of processing underlie decline in verbal fluency following DBS. Behav. Neurol. 2017, 7348101. https://doi.org/10.1155/2017/7348101.
Frenkel-Toledo, S., Giladi, N., Peretz, C., Herman, T., Gruendlinger, L. & Hausdorff, J. M. (2005). Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson’s disease. Mov Disord, 20(9), 1109-1114. https://doi.org/10.1002/mds.20507.
Fukunaga, J. Y., Quitschal, R. M., Doná, F., Ferraz, H. B., Ganança, M. M. & Caovilla, H. H. (2014). Postural control in Parkinson’s disease. Braz J Otorhinolaryngol. 80(6), 508-14. https://doi.org/10.1016/j.bjorl.2014.05.032.
Gironell, A., Pascual-Sedano, B., Aracil, I., Marín-Lahoz, J., Pagonabarraga, J., & Kulisevsky, J. (2018). Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification. Parkinson's disease. 2018, 4327597. https://doi.org/10.1155/2018/4327597.
Glover, G. H. (2011). Overview of functional magnetic resonance imaging. Neurosurgery clinics of North America, 22(2), 133–vii. https://doi.org/10.1016/j.nec.2010.11.001.
Gövert F., Becktepe J. & Deuschl G. (2018). The new tremor classification of the International Parkinson and Movement Disorder Society: Update on frequent tremors. Nervenarzt. 89(4), 376-385. https://doi.org/10.1007/s00115-018-0489-1.
Graebner, A. K., Tarsy, D., Shih, L. C., Vanderhorst, V., Kulkarni, O., Kaplan, S. & Simon, D. K. (2017). Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center. Neurodegenerative diseases. 17(1), 38-43. https://doi.org/10.1159/000447561.
Haehner, A., Hummel, T. & Reichmann, H. (2014). A clinical approach towards smell loss in Parkinson's disease. Journal of Parkinson's disease. 4(2), 189-95. https://doi.org/10.3233/JPD-130278.
Hawkes, C. H., Del Tredici, K. & Braak, H. (2007). Parkinson's disease: a dual-hit hypothesis. Neuropathology and applied neurobiology. 33(6), 599-614. https://doi.org/10.1111/j.1365-2990.2007.00874.x.
Heim, B., Krismer, F., De Marzi, R. & Seppi, K. (2017). Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna). 124(8), 915-964. https://doi.org/10.1007/s00702-017-1717-8.
Heremans, E., Nackaerts, E., Vervoort, G., Broeder, S., Swinnen, S. P., & Nieuwboer, A. (2016). Impaired Retention of Motor Learning of Writing Skills in Patients with Parkinson's Disease with Freezing of Gait. PloS one, 11(2), e0148933. https://doi.org/10.1371/journal.pone.014893.
Högl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Schrag, A. & Goetz, C. G. (2010). Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord. 25(16), 2704-16. https://doi.org/10.1002/mds.23190.
Janiri, D., Petracca, M., Moccia, L., Tricoli, L., Piano, C., Bove, F., Imbimbo, I., Simonetti, A., Di Nicola, M., Sani, G., Calabresi, P. & Bentivoglio, A. R. (2020). COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly. Frontiers in psychiatry, 11, 581144. https://doi.org/10.3389/fpsyt.2020.581144.
Jiao, Z., Zhang, W., Chen, C., Zhu, X., Chen, X., Zhou, M., Peng, G., Liu, H., Qiu, J., Lin, Y., Huang, S., Mo, M., Yang, X., Qu, S. & Xu, P. (2019). Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease. ACS Chem Neurosci. 10(2), 803-811. https://doi.org/10.1021/acschemneuro.8b00373.
Jost, W. H. (2017). Autonomic Dysfunction in Parkinson's disease: Cardiovascular Symptoms, Thermoregulation, and Urogenital Symptoms. Int Rev Neurobiol. 134, 771-785. https://doi.org/10.1016/bs.irn.2017.04.003.
Kim, J., Jang, S., Choe, H. K., Chung, S., Son, G. H. & Kim, K. (2017). Implications of Circadian Rhythm in Dopamine and Mood Regulation. Molecules and cells. 40(7), 450-456. https://doi.org/10.14348/molcells.2017.0065.
Kwok, J. Y. Y., Smith, R., Chan, L. M. L., Lam, L. C. C., Fong, D. Y. T., Choi, E. P. H., Lok, K. Y. W., Lee, J. J., Auyeung, M. & Bloem, B. R. (2022). Managing freezing of gait in Parkinson's disease: a systematic review and network meta-analysis. J Neurol, 10.1007/s00415-022-11031-z. Advance online publication. https://doi.org/10.1007/s00415-022-11031-z.
Lee, T. K. & Yankee, E. L. (2021). A review on Parkinson’s disease treatment. Neuroimunol Neuroinflamation, 8, 222. https://doi.org/10.20517/2347-8659.2020.58
Lill, C. M. (2016). Genetics of Parkinson's disease. Molecular and cellular probes, 30(6), 386–396. https://doi.org/10.1016/j.mcp.2016.11.001.
Lima, M. S., Mangilli, L. D., Sassi, F. C. & Andrade, C. R. F. (2015). Functional magnetic resonance and swallowing: critical literature review. Braz J Otorhinolaryngol. 81(6), 671-680. https://doi.org/10.1016/j.bjorl.2015.08.006.
Lopes, M. S., Melo, A. S., Corona, A. P. & Nóbrega, A. C. (2018). Is there auditory impairment in parkinson’s disease? REV. CEFAC. 20(5), 573-582. https://doi.org/ 10.1590/1982-021620182052418.
Lotankar, S., Prabhavalkar, K. S. & Bhatt, L. K. (2017). Biomarkers for Parkinson's Disease: Recent Advancement. Neuroscience bulletin. 33(5), 585-597. https://doi.org/10.1007/s12264-017-0183-5.
Lozano, C. S., Tam, J., & Lozano, A. M. (2018). The changing landscape of surgery for Parkinson’s disease. Mov. Disord. 33(1), 36–47. https://doi.org/10.1002/mds.27228.
Lunati, A., Lesage, S. & Brice, A. (2018). The genetic landscape of Parkinson's disease. Rev Neurol (Paris). 174(9), 628-643. https://doi.org/10.1016/j.neurol.2018.08.004.
Magalhães, F., Rocha, K., Marinho, V., Ribeiro, J., Oliveira, T., Ayres, C., Bento, T., Leite, F., Gupta, D., Bastos, V. H., Velasques, B., Ribeiro, P., Orsini, M. & Teixeira, S. (2018). Neurochemical changes in basal ganglia affect time perception in parkinsonians. Journal of biomedical science. 25(1), 26. https://doi.org/10.1186/s12929-018-0428-2.
McDermott, K. L., Fisher, N., Bradford, S. & Camicioli, R. (2017). Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms. Int Psychogeriatr. 30(2), 253-260. https://doi.org/10.1017/S1041610217002265.
McKeith, I. G., Ferman, T. J., Thomas, A. J., Blanc, F., Boeve, B. F., Fujishiro, H., Kantarci, K., Muscio, C., O'Brien, J. T., Postuma, R. B., Aarsland, D., Ballard, C., Bonanni, L., Donaghy, P., Emre, M., Galvin, J. E., Galasko, D., Goldman, J. G., Gomperts, S. N., Honig, L. S., Ikeda, M., Leverenz, J. B., Lewis, S. J. G., Marder, K. S., Masellis, M., Salmon, D. P., Taylor, J. P., Tsuang, D. W., Walker, Z. & Tiraboschi, P. (2020). Diagnostic Study Group. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 94(17), 743-755. https://doi.org/10.1212/WNL.0000000000009323.
Mcnamara, P. (2011). The Cognitive Neuropsychiatry of Parkinson’s Disease. The Massachusetts Institute of Technology Press, 87–109.
Mercuri, N. B. & Bernardi, G. (2005). The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci. 26(7), 341-344. https://doi.org/10.1016/j.tips.2005.05.002.
Mikami, K., Shiraishi, M., Kawasaki, T. & Kamo, T. (2017). Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position. Plos One. 12(7), e0181210. https://doi.org/10.1371/journal.pone.0181210.
Ming, W., Palidis, D. J., Spering, M. & Mckeown, M. J. (2016). Visual contrast sensitivity in early-stage Parkinson’s disease. Investigative Ophthalmology & Visual Science. 57, 5696–5704. https://doi.org/10.1167/iovs.16-20025.
Moon, H. E. & Paek, S. H. (2015). Mitochondrial Dysfunction in Parkinson's Disease. Exp Neurobiol. 24(2), 103-16. https://doi.org/10.5607/en.2015.24.2.103.
Mulak, A. & Bonaz, B. (2015). Brain-gut-microbiota axis in Parkinson's disease. World journal of gastroenterology. 21(37), 10609–10620. https://doi.org/10.3748/wjg.v21.i37.10609.
Noyce, A. J., Dickson, J., Rees, R. N., Bestwick, J. P., Isaias, I. U., Politis, M., Giovannoni, G., Warner, T. T., Lees, A. J. & Schrag, A. (2018). Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease. Movement Disorders, 33(3), 478-482. https://doi.org/10.1002/mds.27282.
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Teo, W. P., Hendy, A. M. & Macpherson, H. (2022). To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson's Disease. Front Microbiol. 13, 791213. https://doi.org/10.3389/fmicb.2022.791213.
Pfeiffer, R. F. (2020). Autonomic Dysfunction in Parkinson's Disease. Neurotherapeutics. 17(4), 1464-1479. https://doi.org/10.1007/s13311-020-00897-4.
Pikstra, A. R. A., Van Der Hoorn, A., Leenders, K. L. & De Jong, B. M. (2016). Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson's disease. NeuroImage Clinical. 11, 68-72. https://doi.org/10.1016/j.nicl.2016.01.010.
Politis, M., Pagano, G. & Niccolini, F. (2017). Imaging in Parkinson's Disease. International review of neurobiology. 132, 233-274. https://doi.org/10.1016/bs.irn.2017.02.015.
Reichmann, H. (2017). Premotor Diagnosis of Parkinson's Disease. Neuroscience bulletin. 33(5), 526-534. https://doi.org/10.1007/s12264-017-0159-5.
Rhodes, C. J. (2017). Magnetic resonance spectroscopy. Science Progress. 241-292. https://doi.org/10.3184/003685017X14993478654307.
Ridder, A., Müller, M. L., Kotagal, V., Frey, K. A., Albin, R. L. & Bohnen, N. I. (2017). Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related disorders. 34, 15-19. https://doi.org/10.1016/j.parkreldis.2016.10.006.
Rodríguez-Violante, M., Zerón-Martínez, R., Cervantes-Arriaga, A. & Corona, T. (2017). Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms. Arch Med Res. 48(3), 221-227. https://doi.org/10.1016/j.arcmed.2017.08.005.
Seifert, K. D. & Wiener, J. I. (2013). The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study. American journal of neurodegenerative disease. 2(1), 29–34.
Sharma, M., Naik, V. & Deogaonkar, M. (2016). Emerging applications of deep brain stimulation. J. Neurosurg. Sci. 60(2), 242–255.
Simon, D. K., Tanner, C. M. & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 36(1), 1-12. https://doi.org/10.1016/j.cger.2019.08.002. https://doi.org/10.1016/j.cger.2019.08.002.
Sousa, A. S., Oliveira, S. O., Alves, L H. (2021). A Pesquisa Bibliográfica: Princípios e Fundamentos. Cadernos da Fucamp, 20(43), 64-83.
Stojkovska, I., Wagner, B. M., & Morrison, B. E. (2015). Parkinson's disease and enhanced inflammatory response. Experimental biology and medicine (Maywood, N.J.), 240(11), 1387–1395. https://doi.org/10.1177/1535370215576313.
Sung, S., Vijiaratnam, N., Chan, D. W. C., Farrell, M. & Evans, A. H. (2018). Parkinson disease: A systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation. Journal of the neurological sciences. 395, 172-206. https://doi.org/10.1016/j.jns.2018.10.013.
Sveinbjornsdottir, S. (2016). The clinical symptoms of Parkinson's disease. J Neurochem. 139 Suppl 1, 318–324. https://doi.org/10.1111/jnc.13691.
Targa, A. D., Rodrigues, L. S., Noseda, A. C., Aurich, M. F., Andersen, M. L., Tufik, S., da Cunha, C. & Lima, M. M. (2016). Unraveling a new circuitry for sleep regulation in Parkinson's disease. Neuropharmacology. 108, 161-71. https://doi.org/10.1016/j.neuropharm.2016.04.018.
Timpka, J., Fox, T., Fox, K., Honig, H., Odin, P. & Martinez-Martin, P. (2016). Improvement of dyskinesias with L-dopa infusion in advanced Parkinson’s disease. Acta Neurol. Scand. 133, 451–458. https://doi.org/10.1111/ane.12483.
Tokushige, S. I., Terao, Y., Matsuda, S., Furubayashi, T., Sasaki, T., Inomata-Terada S., Yugeta A., Hamada, M., Tsuji, S. & Ugawa, Y. (2018). Does the Clock Tick Slower or Faster in Parkinson's Disease? Insights Gained from the Synchronized Tapping Task. Frontiers in psychology. 11(9), 1178. https://doi.org/10.3389/fpsyg.2018.01178.
Vázquez-Vélez, G. E., & Zoghbi, H. Y. (2021). Parkinson's Disease Genetics and Pathophysiology. Annual review of neuroscience, 44, 87–108. https://doi.org/10.1146/annurev-neuro-100720-034518
Vercruysse, S., Gilat, M., Shine, J. M., Heremans, E., Lewis, S. & Nieuwboer, A. (2014). Freezing beyond gait in Parkinson's disease: a review of current neurobehavioral evidence. Neurosci Biobehav Rev. 43, 213-27. https://doi.org/10.1016/j.neubiorev.2014.04.010.
Wang, G., Xie, H., Hou, S., Chen, W., Zhao, Q. & Li, S. (2015). Development of the 1.2 T~1.5 T Permanent Magnetic Resonance Imaging Device and Its Application for Mouse Imaging. BioMed research international. 2015, 858694. https://doi.org/10.1155/2015/858694.
World Health Organization (WHO) (2022). Mental health and COVID-19: Early evidence of the pandemic’s impact. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1
Yan, F., Chen, Y., Li, M., Wang, Y., Zhang, W., Chen, X. & Ye, Q. (2018). Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease. Medicine (Baltimore). 97(28), e11337. https://doi.org/10.1097/MD.0000000000011337.
Yoshii, F., Moriya, Y., Ohnuki, T., Ryo, M. & Takahashi, W. (2016). Postural deformities in Parkinson's disease - Mutual relationships among neck flexion, fore-bent, knee-bent and lateral-bent angles and correlations with clinical predictors. J Clin Mov Disord. 3, 1. https://doi.org/10.1186/s40734-016-0029-8.
Zhou, H., Arias-Ramos, N., López-Larrubia, P., Mason, R. P., Cerdán, S. & Pacheco-Torres, J. (2018). Oxygenation Imaging by Nuclear Magnetic Resonance Methods. Methods in molecular biology. 1718, 297-313. https://doi.org/10.1007/978-1-4939-7531-0_18.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Francisco Magalhães; Valécia Natália Carvalho da Carvalho; Jacks Renan Neves Fernandes; Antonio Thomaz de Oliveira; Thayaná Ribeiro Silva Fernandes ; Silmar Teixeira
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Los autores que publican en esta revista concuerdan con los siguientes términos:
1) Los autores mantienen los derechos de autor y conceden a la revista el derecho de primera publicación, con el trabajo simultáneamente licenciado bajo la Licencia Creative Commons Attribution que permite el compartir el trabajo con reconocimiento de la autoría y publicación inicial en esta revista.
2) Los autores tienen autorización para asumir contratos adicionales por separado, para distribución no exclusiva de la versión del trabajo publicada en esta revista (por ejemplo, publicar en repositorio institucional o como capítulo de libro), con reconocimiento de autoría y publicación inicial en esta revista.
3) Los autores tienen permiso y son estimulados a publicar y distribuir su trabajo en línea (por ejemplo, en repositorios institucionales o en su página personal) a cualquier punto antes o durante el proceso editorial, ya que esto puede generar cambios productivos, así como aumentar el impacto y la cita del trabajo publicado.
